September 12, 2023
FDA approves updated COVID-19 boosters
Editor's Note
The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports.
The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6 months to 11 years, must now be signed off by a Centers for Disease Control and Prevention (CDC) advisory panel.
The vaccines will be free for most Americans with health insurance, and the US government is working on a program to provide the vaccines for free to those without insurance, the report says.
Free Daily News
- Assistance program leads to major drop in ER visits, costs for immigrants
- Anesthesia & Analgesia journal devotes October issue to DEI
- Long nursing shifts in mental health wards lead to increased patient incidents
- Closing keynote: Revolutionizing Healthcare with Artificial Intelligence (AI)—Reducing Administrative Burden and Improving Staff Satisfaction
- Postoperative session: PACU Boarding and Patient Experience—There are No Beds in the House!
- Leadership session: Empowering Your Team to Ensure Patient Safety
- ASC luncheon: Quality Measure Reporting Updates for ASCs
- Leadership session: Establishing an Environment of Continuous Improvement
- Business session: Profitability in the OR—Benchmark Your OR's Performance
- Leadership session: Managing Disruptive Behavior—A New Approach to Better Communication
- Pediatric Surgeon - Carilion Clinic - Roanoke, VA
- RN- Surgery (FT) $10,000 Hiring Incentives! - Spencer Hospital - Spencer, IA
- Vascular Surgeon Opportunity at Tertiary Care and Level II Trauma Center in Beautiful New England - Northern Light Eastern Maine Medical Center - Bangor, ME
- RN- Inpatient Services (FT) $15,000 Hiring Incentive! - Spencer Hospital - Spencer, IA
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity Inclusion & Equity